Recombinant Human LILRA3 (C-6His)

Description

EnkiLife provides the Recombinant Human LILRA3 (C-6His) protein,aslo know as Leukocyte immunoglobulin-like receptor subfamily A member 3,CD85 antigen-like family member E,Immunoglobulin-like transcript 6,ILT-6,Leukocyte immunoglobulin-like receptor 4,LIR-4 and Monocyte inhibitory receptor HM43/HM31, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 3 is produced by our Mammalian expression system and the target gene encoding Thr19-Glu439 is expressed with a 6His tag at the C-terminus.Accession:AAH28208.1. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:46.6 KDa. Background:Leukocyte immunoglobulin-like receptor subfamily A member 3 is also known as CD85 antigen-like family member E, Immunoglobulin-like transcript 6, ILT-6, Leukocyte immunoglobulin-like receptor 4, LIR-4 and Monocyte inhibitory receptor HM43/HM31. In humans, it is encoded by the LILRA3 gene. It acts as soluble receptor for class I MHC antigens. Binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1 or LILRB2.It is detected in B-cells, natural killer (NK) cells, peripheral blood monocytes and lung.